<?xml version='1.0' encoding='utf-8'?>
<document id="22877817"><sentence text="Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)."><entity charOffset="48-62" id="DDI-PubMed.22877817.s1.e0" text="phenolic acids" /></sentence><sentence text="Phenolic acids exert beneficial health effects such as anti-oxidant, anti-carcinogenic, and anti-inflammatory activities and show systemic exposure after consumption of common fruits, vegetables, and beverages"><entity charOffset="0-14" id="DDI-PubMed.22877817.s2.e0" text="Phenolic acids" /></sentence><sentence text=" However, knowledge regarding which components convey therapeutic benefits and the mechanism(s) by which they cross cell membranes is extremely limited" /><sentence text=" Therefore, we determined the inhibitory effects of nine food-derived phenolic acids, p-coumaric acid, ferulic acid, gallic acid, gentisic acid, 4-hydroxybenzoic acid, protocatechuic acid, sinapinic acid, syringic acid, and vanillic acid, on human organic anion transporter 1 (hOAT1), hOAT3, and hOAT4"><entity charOffset="70-84" id="DDI-PubMed.22877817.s4.e0" text="phenolic acids" /><entity charOffset="86-101" id="DDI-PubMed.22877817.s4.e1" text="p-coumaric acid" /><entity charOffset="103-115" id="DDI-PubMed.22877817.s4.e2" text="ferulic acid" /><entity charOffset="117-128" id="DDI-PubMed.22877817.s4.e3" text="gallic acid" /><entity charOffset="130-143" id="DDI-PubMed.22877817.s4.e4" text="gentisic acid" /><entity charOffset="145-166" id="DDI-PubMed.22877817.s4.e5" text="4-hydroxybenzoic acid" /><entity charOffset="168-187" id="DDI-PubMed.22877817.s4.e6" text="protocatechuic acid" /><entity charOffset="189-203" id="DDI-PubMed.22877817.s4.e7" text="sinapinic acid" /><entity charOffset="205-218" id="DDI-PubMed.22877817.s4.e8" text="syringic acid" /><entity charOffset="224-237" id="DDI-PubMed.22877817.s4.e9" text="vanillic acid" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e0" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e0" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e1" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e1" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e2" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e2" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e3" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e3" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e4" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e4" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e5" e2="DDI-PubMed.22877817.s4.e5" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e5" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e5" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e5" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e5" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e6" e2="DDI-PubMed.22877817.s4.e6" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e6" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e6" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e6" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e7" e2="DDI-PubMed.22877817.s4.e7" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e7" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e7" e2="DDI-PubMed.22877817.s4.e9" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e8" e2="DDI-PubMed.22877817.s4.e8" /><pair ddi="false" e1="DDI-PubMed.22877817.s4.e8" e2="DDI-PubMed.22877817.s4.e9" /></sentence><sentence text=" In the present study, inhibition of OAT-mediated transport of prototypical substrates (1 μM) by phenolic acids (100 μM) was examined in stably expressing cell lines"><entity charOffset="97-111" id="DDI-PubMed.22877817.s5.e0" text="phenolic acids" /></sentence><sentence text=" All compounds significantly inhibited hOAT3 transport, while just ferulic, gallic, protocatechuic, sinapinic, and vanillic acid significantly blocked hOAT1 activity"><entity charOffset="100-109" id="DDI-PubMed.22877817.s6.e0" text="sinapinic" /><entity charOffset="115-128" id="DDI-PubMed.22877817.s6.e1" text="vanillic acid" /><pair ddi="false" e1="DDI-PubMed.22877817.s6.e0" e2="DDI-PubMed.22877817.s6.e0" /><pair ddi="false" e1="DDI-PubMed.22877817.s6.e0" e2="DDI-PubMed.22877817.s6.e1" /></sentence><sentence text=" Only sinapinic acid inhibited hOAT4 (~35%)"><entity charOffset="6-20" id="DDI-PubMed.22877817.s7.e0" text="sinapinic acid" /></sentence><sentence text=" For compounds exhibiting inhibition &gt; ~60%, known clinical plasma concentration levels and plasma protein binding in humans were examined to select compounds to evaluate further with dose-response curves (IC(50) values) and drug-drug interaction (DDI) index determinations" /><sentence text=" IC(50) values ranged from 1" /><sentence text="24 to 18" /><sentence text="08 μM for hOAT1 and from 7" /><sentence text="35 to 87" /><sentence text="36 μM for hOAT3" /><sentence text=" Maximum DDI indices for gallic and gentisic acid (≫0"><entity charOffset="36-49" id="DDI-PubMed.22877817.s14.e0" text="gentisic acid" /></sentence><sentence text="1) indicated a very strong potential for DDIs on hOAT1 and/or hOAT3" /><sentence text=" This study indicates that gallic acid from foods or supplements, or gentisic acid from salicylate-based drug metabolism, may significantly alter the pharmacokinetics (efficacy and toxicity) of concomitant therapeutics that are hOAT1 and/or hOAT3 substrates"><entity charOffset="27-38" id="DDI-PubMed.22877817.s16.e0" text="gallic acid" /><entity charOffset="69-82" id="DDI-PubMed.22877817.s16.e1" text="gentisic acid" /><entity charOffset="88-98" id="DDI-PubMed.22877817.s16.e2" text="salicylate" /><pair ddi="false" e1="DDI-PubMed.22877817.s16.e0" e2="DDI-PubMed.22877817.s16.e0" /><pair ddi="false" e1="DDI-PubMed.22877817.s16.e0" e2="DDI-PubMed.22877817.s16.e1" /><pair ddi="false" e1="DDI-PubMed.22877817.s16.e0" e2="DDI-PubMed.22877817.s16.e2" /><pair ddi="false" e1="DDI-PubMed.22877817.s16.e1" e2="DDI-PubMed.22877817.s16.e1" /><pair ddi="false" e1="DDI-PubMed.22877817.s16.e1" e2="DDI-PubMed.22877817.s16.e2" /></sentence><sentence text="" /></document>